InflaRx presented data analyses from a terminated Phase 3 study on the potential treatment for rare skin condition.

Encoded Therapeutics has linked its Dravet syndrome gene therapy ETX101 to a 78% reduction in seizures, keeping the biotech on track to start a pivotal study next year. The Californian company’s ...

The PATH transit system rolled out its new, reloadable TAPP (Total Access PATH Payment) fare card on Thursday as Port Authority moves toward phasing out its antiquated MetroCard and SmartLink systems ...

The Port Authority of New York and New Jersey has launched a new reloadable TAPP card for PATH riders. TAPP use has grown dramatically as its been integrated into the system. Nearly 70% of weekday ...

Achieve financial well-being with simple, time-tested strategies tailored to the three stages of wealth: accumulation, conservation, and distribution. During accumulation, blend QQQ, SPY, and DIA for ...

Phase 2 of the Conway Rec Path is in limbo now that the estimated cost of building it has doubled and selectmen refuse to sign off on a grant modification the Mount Washington Valley Trails ...

Key Laboratory of Materials Modification by Laser, Ion and Electron Beams (Dalian University of Technology), Ministry of Education, School of Physics, Dalian 116024, China Key Laboratory of Materials ...

BridgeBio has vaulted over the success bar it set for a phase 3 rare disease trial, linking the candidate to significant improvements on biomarker and clinical outcomes to tee up a filing for FDA ...

Keio University, Department of Mechanical Engineering, 3-14-1 Hiyoshi, Kohoku-Ku, Yokohama, Kanagawa 223-8522, Japan ...

Forbes contributors publish independent expert analyses and insights. An award-winning reporter writing about stargazing and the night sky. A total lunar eclipse — also known as a “Blood Moon” — is a ...